Skip Navigation


NDT Advance Access originally published online on March 19, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/6/1398    most recent
gfh204v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Foglia, P. E. G.
Right arrow Articles by Bianchetti, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foglia, P. E. G.
Right arrow Articles by Bianchetti, M. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2004) 19: 1398-1402
Nephrol Dial Transplant Vol. 19 No. 6 © ERA-EDTA 2004; all rights reserved


Original Article

Cardiac work up in primary renal hypokalaemia-hypomagnesaemia (Gitelman syndrome)

Pietro E. G. Foglia1,2, Alberto Bettinelli1,3, Camillo Tosetto4, Cinzia Cortesi1,2, Laura Crosazzo1,2, Alberto Edefonti1 and Mario G. Bianchetti1,2

1Pediatric Renal Unit, University of Milan Medical School, Clinica De Marchi, Milan, Italy, 2Department of Pediatrics, San Giovanni Hospital, Bellinzona, Switzerland, 3Division of Pediatrics, Leopoldo Mandic Hospital, Merate, Italy and 4Division of Cardiology, Casa di Cura Santa Maria, Castellanza, Italy

Correspondence and offprint requests to: Mario G. Bianchetti, Department of Pediatrics, San Giovanni Hospital, CH-6500 Bellinzona, Switzerland. Email: mario.bianchetti{at}pediatrician.ch

Background. Potassium and magnesium depletion prolongs the duration of the action potential of the cardiomyocyte, which predisposes to ventricular arrhythmias. In addition, potassium or magnesium depletion might impair cardiac performance and facilitate coronary artery thrombosis.

Methods. Continuous 24-h ambulatory electrocardiographic monitoring, treadmill exercise testing and echocardiography were assessed in 21 patients (11 female and 10 male subjects, aged 5.9–39, median 19 years) with primary renal hypokalaemia-hypomagnesaemia.

Results. The QT interval corrected for heart rate was normal (between 379 and 430 ms) in 10 and slightly to moderately prolonged in the remaining 11 patients (between 446 and 509 ms). Plasma potassium, magnesium and bicarbonate were similar in patients with normal and in those with prolonged QT interval. Continuous ambulatory electrocardiography over 24 h and exercise testing did not detect significant abnormalities of cardiac rhythm or features suggestive of myocardial ischaemia. Finally, echocardiographic and Doppler assessment failed to reveal any abnormalities in myocardial morphology and function.

Conclusion. The QT interval is often prolonged in primary renal hypokalaemia-hypomagnesaemia, confirming that potassium and magnesium depletion tends to prolong the duration of the action potential of the cardiomyocyte. The results of continuous ambulatory electrocardiography, exercise testing and echocardiography are reassuring. Nonetheless, we assume that dangerous cardiac arrhythmias may occur in patients with very severe hypokalaemia, during medication with drugs that prolong the QT interval or in the context of short-term non-adherence to the recommended regimen of care.

Keywords: echocardiography; exercise testing; Gitelman syndrome; Holter monitoring; QT interval


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
HypertensionHome page
D. H. Ellison and J. Loffing
Thiazide Effects and Adverse Effects: Insights From Molecular Genetics
Hypertension, August 1, 2009; 54(2): 196 - 202.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
B. Zimmermann, C. Plank, M. Konrad, W. Stohr, C. Gravou-Apostolatou, W. Rascher, and J. Dotsch
Hydrochlorothiazide in CLDN16 mutation
Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2127 - 2132.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. Cortesi, A. Bettinelli, F. Emma, M. Fischbach, P. Bertolani, and M. G. Bianchetti
Severe syncope and sudden death in children with inborn salt-losing hypokalaemic tubulopathies
Nephrol. Dial. Transplant., September 1, 2005; 20(9): 1981 - 1983.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Stowasser, J. Sharman, R. Leano, R. D. Gordon, G. Ward, D. Cowley, and T. H. Marwick
Evidence for Abnormal Left Ventricular Structure and Function in Normotensive Individuals with Familial Hyperaldosteronism Type I
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5070 - 5076.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. T. Pachulski, F. Lopez, and R. Sharaf
Gitelman's Not-So-Benign Syndrome
N. Engl. J. Med., August 25, 2005; 353(8): 850 - 851.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.